At this BASG discussion, we will inform you about current and future developments in the field of GLP.
Contents
- The new position paper: IT security in the context of GLP (Dr Alexander Weninger)
- GLP requirements in clinical trials (Mag. Robert Klaus)
- Preclinical requirements for the authorisation of biosimilars (Dr Manfred Schuster)
Use of in-silico toxicology models in drug approval (Dr Manfred Schuster
)
Target group
- Preclinical testing facilities, quality consultants
Language
German
Registration information
Please registerat by 21 November 2025 at the latest.
This event will be held as a hybrid event (participation online or in person on site possible).
Technical management
Dr Ronald Bauer
Institute for Surveillance
Medical Market Surveillance Business Unit, AGES GmbH